Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.
2. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Schlag P. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res. 1990;50:5790–4.
3. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology. 1998;55(2):130–8.
4. Ihemelandu C. The landmark series: scoring systems for primary peritoneal surface malignancy. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12941-y.
5. González-Moreno S, Kusamura S, Baratti D, Deraco M. Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol. 2008;98(4):237–41. https://doi.org/10.1002/jso.21072.